Arbutus Biopharma Corporation (ABUS) stock prices updated...
 

Arbutus Biopharma Corporation stock price

Arbutus Biopharma Corporation latest news:


  • 07/27/2017 10:37:17

    BRIEF-Arbutus expects to take two experimental hep B drugs into human studies by mid-2018 - CEO

    * Arbutus Biopharma expects to take two of its preclinical hep B drugs-in-development into human studies by mid-2018 - ceo Further company coverage:

  • More trends:

    ARC Group Worldwide, Inc.ARCW | ARCA biopharma, Inc.ABIO | Arcadia Biosciences, Inc.RKDA | ArcBest CorporationARCB | Arch Capital Group Ltd.ACGL | Arctic Cat Inc.ACAT | Ardelyx, Inc.ARDX | Arena Pharmaceuticals, Inc.ARNA | Ares Capital CorporationARCC | Argo Group International Holdings, Ltd.AGII |